CCDC160 inhibitors are a class of chemical compounds designed to specifically target and modulate the activity of the CCDC160 protein, a member of the coiled-coil domain-containing (CCDC) protein family. Proteins in this family are typically involved in structural and regulatory functions within the cell, often participating in processes such as intracellular transport, scaffolding, and protein-protein interactions. Although the exact biological role of CCDC160 is still under investigation, it is believed to play a part in cellular architecture and the organization of protein complexes. Inhibitors of CCDC160 are developed to disrupt its normal function, allowing researchers to study the impact of its inhibition on cellular processes and to better understand the protein's role within the cell.
The development of CCDC160 inhibitors begins with a comprehensive analysis of the protein's structure and functional domains. Structural biology techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to determine the three-dimensional structure of CCDC160. This structural data is crucial for identifying potential binding sites for inhibitors, particularly within the coiled-coil regions or other domains essential for the protein's interactions and function. Computational methods, including molecular docking and virtual screening, are then used to identify small molecules that can effectively bind to these sites with high specificity and affinity. Once potential inhibitors are identified, they are synthesized and tested in various biochemical assays to evaluate their ability to inhibit CCDC160's activity. These assays assess factors such as binding affinity, selectivity, and the effects of inhibition on cellular functions related to CCDC160. Through iterative cycles of chemical modification and testing, these inhibitors are optimized to enhance their effectiveness and stability. The study of CCDC160 inhibitors not only aids in deciphering the specific functions of this protein but also contributes to a broader understanding of the regulatory mechanisms that govern cellular organization and protein complex formation.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, potentially affecting cell growth and autophagy pathways relevant to CCDC160. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, potentially impacting AKT signaling pathways that could intersect with CCDC160 functions. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, possibly influencing protein degradation pathways linked to CCDC160. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, potentially altering gene expression patterns relevant to CCDC160. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, potentially affecting the MAPK/ERK signaling pathway relevant to CCDC160. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multi-kinase inhibitor, potentially impacting cell proliferation, angiogenesis, and apoptosis pathways related to CCDC160. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, potentially impacting apoptosis pathways that may be relevant to CCDC160. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Broad-spectrum tyrosine kinase inhibitor, potentially affecting multiple signaling pathways related to CCDC160. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Compound from turmeric, potentially modulating various enzyme activities and signaling pathways related to CCDC160. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Multi-kinase inhibitor, potentially influencing angiogenesis and cell proliferation pathways relevant to CCDC160. | ||||||